1 / 12

NOVEL DRUGS AND DEVICES TO LOWER INTRAOCULAR PRESSURE MARKET

Approvals of drugs and devices associated with the treatment of glaucoma from regulatory bodies is expected to boost the global novel drugs and devices to lower intraocular pressure market growth. For instance, in May 2019, Ivantis Inc., received an approval from the U.S. Food and Drug Administration (FDA) for Hydrus microstent. It is a device used in minimally invasive glaucoma surgery. It is developed to lower eye pressure in patients with open angle glaucoma.<br>Furthermore, in September 2018, Sun Pharmaceuticals Industries Ltd. received an approval from U.S. FDA for Xelpros (latanoprost ophthalmic emulsion) for treatment of glaucoma. It reduces the elevated intraocular pressure in the eye and has been designed with the help of Swollen Micelle Micro emulsion technology. Frequent approvals of drugs and devices is expected to accelerate global novel drugs and devices to lower intraocular pressure market growth.<br>

PrashilCMI
Download Presentation

NOVEL DRUGS AND DEVICES TO LOWER INTRAOCULAR PRESSURE MARKET

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. Novel DRUGS AND DEVICES TO LOWER INTRAOCULAR PRESSURE MARKET Intraocular pressure is the pressure present inside the eye. The aqueous humour of the ciliary body in the eye is responsible for the intraocular pressure. The production and removal rate of aqueous humour by the ciliary body determines the pressure in the eye. The presence of extra fluid (aqueous humour) builds up pressure in the eye which can lead to glaucoma. There are two types of glaucoma, open–angle glaucoma and closed–angle glaucoma. Generally, tonometers are used for determining the pressure present in the eye.

  3. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Drivers Approvals of drugs and devices associated with the treatment of glaucoma from regulatory bodies is expected to boost the global novel drugs and devices to lower intraocular pressure market growth. For instance, in May 2019, Ivantis Inc., received an approval from the U.S. Food and Drug Administration (FDA) for Hydrus microstent. It is a device used in minimally invasive glaucoma surgery. It is developed to lower eye pressure in patients with open angle glaucoma. Furthermore, in September 2018, Sun Pharmaceuticals Industries Ltd. received an approval from U.S. FDA for Xelpros (latanoprost ophthalmic emulsion) for treatment of glaucoma. It reduces the elevated intraocular pressure in the eye and has been designed with the help of Swollen Micelle Micro emulsion technology. Frequent approvals of drugs and devices is expected to accelerate global novel drugs and devices to lower intraocular pressure market growth.

  4. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Regional Analysis North America is expected to be dominant in global novel drugs and devices to lower intraocular pressure market during the forecast period. Factors such as government initiatives expected to augment the North America novel drugs and devices to lower intraocular pressure market growth. For instance, in January 2019, Glaucoma Research Foundation, U.S., formed a team called Catalyst for a Cure. The investigators are working together to understand the exact cause of vision loss in glaucoma patients, and potential targeted therapies for the prevention and treatment of glaucoma. As a result, this factor is expected to support the global novel drugs and devices to lower intraocular pressure market growth.

  5. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Restraints Side effects of glaucoma medications are expected to hinder growth of the global novel drugs and devices to lower intraocular pressure market. Side effects of medications used for the treatment of glaucoma, such as Rhopressa, include internal bleeding, corneal deposits, and stinging. Also, the cost of these medications is very high. For instance, 2.5 milliliter’s of Rhopressa (Netarsudil ophthalmic solution) costs around US$269. Hence, these factors are expected to restrain the global novel drugs and devices to lower intraocular pressure market growth.

  6. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Key Players Some of the major players operating in the global novel drugs and devices to lower intraocular pressure market include, Mati Therapeutics Inc, BioLight Lifesciences Ltd., IOPtima Ltd., Eye Sonix, Bausch & Lomb Inc., Sun Pharmaceutical Industries Ltd., Allergan, Alcon Inc., Glaukos Corporation, and Pfizer Inc. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Taxonomy The global novel drugs and devices to lower intraocular pressure market is segmented on the basis of treatment, distribution channel, and region.

  7. By Treatment Type • Drugs • Rhopressa • Roclatan • Xelpros • Vyzulta • Others • Devices • Implant • Therapeutic Ultrasound • Others

  8. By Distribution Channel • Hospitals & Clinics • Retail Channel • Online Channel • By Region • North America • Latin America • Europe • Asia Pacific • Middle East • Africa

  9. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. •  What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs

  11. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  12. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related